Immunogenicity

CIRION has developed over the past 20 years, extensive experience in the field of immunogenicity testing for biologics and biosimilars. This testing is performed to support both pre-clinical and clinical development programs. Regulatory documents have been published outlining key parameters that require appropriate evaluations for assay development and validation.

Immunogenicity testing at CIRION is performed using a multi-tiered approach:

 

Further chatacterization assays can be performed such as:

  • Antibody titer
  • Antibody isotyping
  • Specificity to endogenous molecule
  • Specificity to fusion protein
 
Cell-based assay are also available to evaluate biological activity:
 
  • Pharmacodynamic assay (PD)
  • Undirect detection method fo NAb
 
 
These are only a few examples of what we can do. For more information, or a special request, please contact us toll free at 1-866-688-2474 or by e-mail at businessdevelopment@cirion.com.
 

< back

 

 

 

© 2016 CIRION BioPharma Research Inc. All rights reserved.  Legal notice  Privacy Policy